From the Journals
From the Journals
Mediterranean diet linked to 24% reduction in CVD risk in women
The researchers are calling for more sex-specific research to guide clinical practice.
From the Journals
Holy smoke: Air pollution link to bone damage confirmed
‘The scientific literature ... is clearly pointing toward a negative effect of chronic pollution exposure on bone health,’ says expert. New study...
Latest News
Artificial pancreas ‘superior’ in young kids with type 1 diabetes
“Successful use of the closed-loop system ... is an important finding that could affect the approach to initiating and monitoring the use of the...
From the Journals
Some, not all, ultraprocessed foods linked to type 2 diabetes
The increased risk applies only to certain types of ultraprocessed foods, say researchers, who call for their consumption to be limited.
From the Journals
High caffeine levels may lower body fat, type 2 diabetes risks
Previous short-term studies have linked caffeine intake with reductions in weight and fat mass.
From the Journals
What do I have? How to tell patients you’re not sure
More than one-third of patients are discharged from an emergency department without a clear diagnosis, one analysis estimates.
From the Journals
Factors linked with increased VTE risk in COVID outpatients
While the overall risk for VTE was low, age of at least 55 years, being male, and having a BMI of at least 30 and history of VTE increased the...
From the Journals
Treat together: Tackle heart disease and obesity simultaneously
A new review outlines how obesity can impair common imaging tests used to diagnose heart disease.
From the Journals
Gestational diabetes affects fetal lung development
Exomes associated with diabetes mellitus impeded the growth and maturation of fetal lungs.
From the Journals
Can SGLT2 inhibitors limit acute kidney injury in type 2 diabetes?
Contrary to the initial concerns that SGLT2 inhibitors might increase the risk of acute kidney injury, new data indicate that this complication is...
Conference Coverage
FREEDOM COVID: Full-dose anticoagulation cut mortality but missed primary endpoint
In an in-hospital anticoagulation trial, the primary COVID endpoint was missed but a survival benefit is observed.